VSIG4 expression on macrophages facilitates lung cancer development

Laboratory Investigation

Volumn 94, Issue 7, 2014, Pages 706-715

  Liao, Yunmei ^a   Guo, Sheng ^b   Chen, Yongwen ^b   Cao, Dayan ^b   Xu, Huan ^b   Yang, Chengying ^b   Fei, Lei ^b   Ni, Bing ^b   Ruan, Zhihua ^a  

^a SOUTHWEST HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

immunohistochemistry; lung carcinoma; macrophage; VSIG4

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; PROTEIN; UNCLASSIFIED DRUG; V SET IG DOMAIN CONTAINING 4 PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD3+ T LYMPHOCYTE; CD31+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG CANCER CELL LINE; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUMOR GROWTH; TUMOR MODEL; TUMOR VOLUME;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD274; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; B7 ANTIGENS; CARCINOMA, LEWIS LUNG; CARCINOMA, NON-SMALL-CELL LUNG; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-2; LUNG NEOPLASMS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; RECEPTORS, COMPLEMENT;

EID: 84903535779     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.73     Document Type: Article

References (32)

1. Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307:2418-2429.
2. Boon T, Cerottini JC, Van den Eynde B, et al. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 1994;12:337-365.
3. Wilcox RA, Flies DB, Zhu G, et al. Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. J Clin Invest 2002;109:651-659.
4. Baxter AG, Hodgkin PD. Activation rules: the two-signal theories of immune activation. Nat Rev Immunol 2002;2:439-446.
5. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990;248:1349-1356.
6. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004;4:336-347.
7. Wang YH, Cao YW, Yang XC, et al. Effect of TLR4 and B7-H1 on immune escape of urothelial bladder cancer and its clinical significance. Asian Pac J Cancer Prev 2014;15:1321-1326.
8. Nishimura H, Okazaki T, Tanaka Y, et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001;291: 319-322.
9. Egen JG, Kuhns MS, Allison JP. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 2002;3: 611-618.
10. Konishi J, Yamazaki K, Azuma M, et al. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin Cancer Res 2004;10: 5094-5100.
11. Sun Y, Wang Y, Zhao J, et al. B7-H3 and B7-H4 expression in non-smallcell lung cancer. Lung Cancer 2006;53:143-151.
12. Helmy KY, Katschke Jr KJ, Gorgani NN, et al. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 2006;124:915-927.
13. Lee MY, Kim WJ, Kang YJ, et al. Z39Ig is expressed on macrophages and may mediate inflammatory reactions in arthritis and atherosclerosis. J Leukoc Biol 2006;80:922-928.
14. Vogt L, Schmitz N, Kurrer MO, et al. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. J Clin Invest 2006; 116:2817-2826.
15. Walker MG. Z39Ig is co-expressed with activated macrophage genes. Biochim Biophys Acta 2002;1574:387-390.
16. Kim JK, Choi EM, Shin HI, et al. Characterization of monoclonal antibody specific to the Z39Ig protein, a member of immunoglobulin superfamily. Immunol Lett 2005;99:153-161.
17. Kammula EC, Motter J, Gorgels A, et al. Brain transcriptome-wide screen for HIV-1 Nef protein interaction partners reveals various membrane-associated proteins. PLoS One 2012;7:12.
18. Guo S, Yang C, Mei F, et al. Down-regulation of Z39Ig on macrophages by IFN-gamma in patients with chronic HBV infection. Clin Immunol 2010;136:282-291.
19. Fleming ID, Phillips JL, Menck HR, et al. The National Cancer Data Base report on recent hospital cancer program progress toward complete American Joint Committee on Cancer/TNM staging. Cancer 1997; 80:2305-2310.
20. Hensing TA. Clinical evaluation and staging of patients who have lung cancer. Hematol Oncol Clin N Am 2005;19:219-235, v.
21. Zhou HJ, Zhang JL, Li A, et al. Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro. Cancer Chemother Pharm 2010;66:21-29.
22. Euhus DM, Hudd C, LaRegina MC, et al. Tumor measurement in the nude mouse. J Surg Oncol 1986;31:229-234.
23. Benson JR. Role of transforming growth factor beta in breast carcinogenesis. Lancet Oncol 2004;5:229-239.
24. Hill M, Bausero M, Mazal D, et al. Immunobiological characterization of N-nitrosomethylurea-induced rat breast carcinomas: tumoral IL-10 expression as a possible immune escape mechanism. Breast Cancer Res Treat 2004;84:107-116.
25. Liyanage UK, Moore TT, Joo HG, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002;169:2756-2761.
26. Singh S, Ross SR, Acena M, et al. Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells. J Exp Med 1992;175:139-146.
27. Spiotto MT, Yu P, Rowley DA, et al. Increasing tumor antigen expression overcomes 'ignorance' to solid tumors via crosspresentation by bone marrow-derived stromal cells. Immunity 2002;17: 737-747.
28. Zou WP. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 2005;5:263-274.
29. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004;4:71-78.
30. Mahnke K, Ring S, Johnson TS, et al. Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: role of B7-H3 expression and antigen presentation. Eur J Immunol 2007;37:2117-2126.
31. Yi KH, Chen L. Fine tuning the immune response through B7-H3 and B7-H4. Immunol Rev 2009;229:145-151.
32. Zhu B, Chen Z, Cheng X, et al. Identification of HLA-A*0201- restricted cytotoxic T lymphocyte epitope from TRAG-3 antigen. Clin Cancer Res 2003;9:1850-1857.